Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 482,375 | 401,858 | 365,978 | 353,874 | 306,486 |
| Cost of Goods | 6,481 | 5,385 | 5,281 | 5,582 | 5,504 |
| Gross Profit | 475,894 | 396,473 | 360,697 | 348,292 | 300,982 |
| Operating Expenses | 369,093 | 284,224 | 236,501 | 220,672 | 189,880 |
| Operating Income | 107,282 | 112,634 | 124,477 | 128,202 | 111,606 |
| Other Income | 17,275 | 3,557 | 529 | 3,400 | 5,070 |
| Pre-tax Income | 124,557 | 116,191 | 125,006 | 131,602 | 116,676 |
| Income Tax | 18,417 | 14,773 | 12,494 | 25,591 | 22,495 |
| Net Income Continuous | 106,140 | 101,418 | 112,512 | 106,011 | 94,181 |
| Net Income | $106,140 | $101,418 | $112,512 | $106,011 | $94,181 |
| EPS Basic Total Ops | 1.02 | 0.95 | 0.97 | 0.92 | 0.82 |
| EPS Basic Continuous Ops | 1.02 | 0.95 | 0.97 | 0.92 | 0.82 |
| EPS Diluted Total Ops | 0.94 | 0.87 | 0.89 | 0.85 | 0.77 |
| EPS Diluted Continuous Ops | 0.95 | 0.87 | 0.89 | 0.85 | 0.77 |
| EPS Diluted Before Non-Recurring Items | 0.94 | 0.87 | 0.89 | 0.85 | 0.77 |
| EBITDA(a) | $100,516 | $117,463 | $133,036 | $130,439 | $113,777 |